Neo-Giluritmal

General characteristics. Structure:

Active ingredient: praymalina of a bitartrate of 20 mg.

Pharmacological properties:

Pharmacological action - antiarrhytmic.

Indications to use:

Tachycardic supraventricular, AV and ventrikulyarny arrhythmias.

Route of administration and doses:

Inside, after food with a small amount of liquid, in an initial dose 1 tablet 3–4 times a day within 2–3 days. At a maintenance therapy the initial dose is gradually reduced to 1/2 tablets by 2–4 times a day. In out-patient conditions it is not necessary to exceed a daily dose in 100 mg, in stationary conditions — 120 mg.

Features of use:

There are no data.

Side effects:

Nausea, feeling of heat, headache, lack of appetite, lock, intra hepatic cholestasia (the increased temperature, an itch, yellowing of a sclera of eyes, coloring of urine in brown color, a light chair), a visual disturbance, a leukopenia, thrombocytopenia, pro-arhythmic effects.

Interaction with other medicines:

Cardiac glycosides or other antiarrhytmic drugs can strengthen bradycardia or negative dromotropic effect.

Contraindications:

Disturbances of AV and intraventricular conductivity, Adams's attacks — Stokes, disturbance of a cordial rhythm against the background of bradycardia, pregnancy.

Overdose:

There are no data.

Storage conditions:

To store in the place, unavailable to children.

Issue conditions:

According to the recipe

Packaging:

1 tablet contains a praymalin of a bitartrate of 20 mg, in packaging of 50 pieces.